Aprea Therapeutics, Inc. (APRE)
0.8335
-0.01
(-1.15%)
USD |
NASDAQ |
May 06, 16:00
0.8398
+0.01
(+0.76%)
Pre-Market: 20:00
Aprea Therapeutics Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Modular Medical, Inc. | -1.222M |
| Ernexa Therapeutics, Inc. | -0.015M |
| Recursion Pharmaceuticals, Inc. | -0.338M |
| Tango Therapeutics, Inc. | -135.72M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.067M |
| Cash from Financing (Quarterly) | 4.004M |
| Free Cash Flow | -13.44M |
| Free Cash Flow Per Share (Quarterly) | -0.3989 |
| Free Cash Flow to Equity (Quarterly) | -3.067M |
| Free Cash Flow to Firm (Quarterly) | -3.067M |
| Free Cash Flow Yield | -246.8% |